Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 291

The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.

Drug-Eluting Stents in Preclinical Studies: Recommended Evaluation From a Consensus Group

Open access
Schwartz, Robert S., Edelman, Elazer R., Carter, Andrew, Chronos, Nicolas, Rogers, Campbell, Robinson, Keith A., Waksman, Ron, Weinberger, Judah, Wilensky, Robert L., Jensen, Donald N., Zuckerman, Bram D., Virmani, Renu·2002·Circulation

Abstract

T he arrival of drug-eluting stents raises important ques- tions about preclinical evaluation of devices and the optimal means of predicting clinical safety and efficacy.The Interventional, Regulatory, Commercial, and Scientific communities have all asked for assistance in defining criteria for device evaluation.This document is an integrated view of requirements for evaluating drug-eluting stents in preclinical models.The suggested requirements encompass study design, experimental performance, and histopathologic evaluations, emphasizing safety and efficacy at multiple points in time.This is a consensus document assembled by clinical, academic, and industrial investigators engaged in preclinical interventional device evaluation.Suggested requirements might well serve as a standard but do not prescribe a single manner in which all devices should be evaluated.They instead motivate such an evaluation and describe how examinations might be performed.It is understood that methods will change and knowledge will evolve, in particular as corroboration is established with clinical data.The dynamic nature of this document allows for future modifications and additions.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1161/01.cir.0000033485.20594.6f

Cites

14 of 14 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 14 references

Cited by

See all 291

Metadata

Authors
Schwartz, R. S., Edelman, E. R., Carter, A., Chronos, N., Rogers, C., Robinson, K. A., Waksman, R., Weinberger, J., Wilensky, R. L., Jensen, D. N., Zuckerman, B. D., & Virmani, R.
Venue
Circulation
Published
2002-10
Volume
106
Issue
14
Pages
1867-1873
ISSN
  • 0009-7322 (ISSN-L)
  • 1524-4539
OpenAlex
W2169000150
Cited by
291
References
14
FWCI
13.31
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Drug-Eluting Stents in Preclinical Studies: Recommended Evaluation From a Consensus Group. https://app.cochat.ai/papers/10.1161/01.cir.0000033485.20594.6f
The paper
Schwartz, R. S., Edelman, E. R., Carter, A., Chronos, N., Rogers, C., Robinson, K. A., Waksman, R., Weinberger, J., Wilensky, R. L., Jensen, D. N., Zuckerman, B. D., & Virmani, R. (2002). Drug-Eluting Stents in Preclinical Studies: Recommended Evaluation From a Consensus Group. Circulation. https://doi.org/10.1161/01.cir.0000033485.20594.6f

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.